- Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide
-
Ro J, Cheng FT, Sriuranpong V, Villalon A, Smruti BK, Tsang J, Yap YS, Asian Working Group for Eribulin Clinical Guide
- KMID: 2176316
- J Breast Cancer.
- 2016 Mar;19(1):8-17.
- doi: 10.4048/jbc.2016.19.1.8
Eribulin, an antimicrotubule chemotherapeutic agent, is approved for the treatment of pretreated metastatic breast cancer (mBC) based on the positive outcomes of phase II and phase III clinical trials, which... -
- CITED
-
- Close
- SHARE
-
- Close
